🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Urothelial carcinoma (UC) is the ninth most common cancer type worldwide. W...
Status
Active Not Recruiting
Location
Highlands Oncology Group - Springdale /ID# 270290
Start Date
2025-01-20
Trial ID
NCT06632951
Treatments Being Tested
This is a Phase 1/1b open-label study evaluating the safety, pharmacokineti...
Status
Completed
Location
HonorHealth Research Institute - Pima /ID# 105677
Start Date
2013-08-08
Trial ID
NCT01946074
Treatments Being Tested
The main objective of this study is to assess safety, tolerability, and pha...
Status
Completed
Location
The University of Chicago Medical Center /ID# 217196
Start Date
2020-01-22
Trial ID
NCT04196283
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Recruiting
Location
City of Hope /ID# 261468
Start Date
2024-01-11
Trial ID
NCT06109272
Treatments Being Tested
This study will be conducted in two stages and will test the safety/tolerab...
Status
Completed
Location
Franco Felizarta, Md /Id# 215721
Start Date
2020-01-30
Trial ID
NCT04223804
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313
Start Date
2023-09-21
Trial ID
NCT05822752
Treatments Being Tested
Cancer is a condition where cells in a specific part of body grow and repro...
Status
Terminated
Location
City of Hope /ID# 254303
Start Date
2024-02-06
Trial ID
NCT06158958
Treatments Being Tested
Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading c...
Status
Active Not Recruiting
Location
Beijing Youan Hospital, Capital Medical University -No differernce with previous /ID# 261928
Start Date
2024-09-11
Trial ID
NCT06487559
Treatments Being Tested
This is a two-part study consisting of Part A (dose regimen finding) follow...
Status
Terminated
Location
University of Alabama /ID# 202249
Start Date
2017-06-14
Trial ID
NCT03138408
This is an open-label, Phase I, dose-escalation study to determine the reco...
Status
Completed
Location
Moores Cancer Center at UC San Diego /ID# 157374
Start Date
2016-12-14
Trial ID
NCT03000257
Treatments Being Tested